Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Ocular Therapeutix, Inc.

OCUL Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of OCUL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
OCUL Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
OCUL Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
OCUL Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in OCUL holdings by institutional investors

Quarterly net insider trading by OCUL's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for OCUL

Quiver Logo

No former government officials on record as having lobbied for OCUL

Revolving Door Dashboard

OCUL Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

OCUL Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
OCUL Income Statement
OCUL Balance Sheet
OCUL Cash Flow
U.S. Patents

New OCUL patent grants

  • Patent Title: Ocular implant containing a tyrosine kinase inhibitor Oct. 28, 2025
  • Patent Title: Ocular implant containing a tyrosine kinase inhibitor Jul. 15, 2025
  • Patent Title: Compositions and methods for treating ocular diseases Jun. 17, 2025
  • Patent Title: Punctal plug and bioadhesives May. 27, 2025
  • Patent Title: Implant injector device Feb. 18, 2025
  • Patent Title: Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent Dec. 10, 2024
  • Patent Title: Punctal plug and bioadhesives Nov. 26, 2024
  • Patent Title: Methods of treating allergic conjunctivitis Nov. 19, 2024
  • Patent Title: Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine Oct. 08, 2024
  • Patent Title: Intracanalicular depot inserter device Jul. 02, 2024
  • Patent Title: Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine Oct. 10, 2023
  • Patent Title: Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles Apr. 11, 2023
  • Patent Title: Punctal plug and bioadhesives Jan. 24, 2023
  • Patent Title: Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor Dec. 27, 2022
  • Patent Title: Punctal plug and bioadhesives Oct. 04, 2022
  • Patent Title: Ocular implant containing a tyrosine kinase inhibitor Sep. 13, 2022
  • Patent Title: Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine May. 17, 2022
  • Patent Title: Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine Apr. 05, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to OCUL from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
OCUL News

Recent insights relating to OCUL

CNBC Recommendations

Recent picks made for OCUL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in OCUL

OCUL Analyst Ratings

OCUL Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
OCUL Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $OCUL stock a Buy, Sell, or Hold?

  • What is the price target for $OCUL stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

OCUL Top Shareholders
Shareholder
Shares Held
OCUL Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $OCUL stock?

  • Who owns the most shares of $OCUL stock?

  • What funds own $OCUL stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

OCUL Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view OCUL Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About OCUL

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

  • Address Bedford, MA
  • Market Cap 2.1 billion
  • Employees 325
  • Industrial Classification Pharmaceutical Preparations

Ocular Therapeutix, Inc. (OCUL) Historical Stock Prices

Ocular Therapeutix, Inc. (OCUL) closed at $9.82 on September 24, 2026. Over the past year its adjusted close ranged from $6.88 to $16.11. Daily prices go back to July 25, 2014, 3,060 trading days in all.

  • 1 month-9.74%
  • 3 months+0.61%
  • Year to date-19.11%
  • 1 year-21.82%
  • 3 years+207.84%
  • 5 years-6.39%
  • Max-25.32%
See every congressional and insider trade on the OCUL price chart

Quiver Premium charts OCUL's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 9.94 9.98 9.60 9.82 9.82 1,864,662
Sep 23, 2026 10.48 10.57 9.77 10.00 10.00 2,089,389
Sep 22, 2026 10.08 10.61 10.02 10.50 10.50 2,495,300
Sep 21, 2026 10.08 10.17 9.81 9.99 9.99 2,073,006
Sep 18, 2026 10.15 10.26 9.89 9.99 9.99 4,100,930
Sep 17, 2026 10.11 10.54 10.05 10.14 10.14 2,311,414
Sep 16, 2026 10.21 10.32 9.81 9.87 9.87 3,405,745
Sep 15, 2026 10.79 10.89 10.13 10.19 10.19 2,098,599
Sep 14, 2026 10.61 10.85 10.49 10.72 10.72 1,623,509
Sep 11, 2026 10.75 10.94 10.37 10.49 10.49 2,638,751
Sep 10, 2026 11.43 11.43 10.54 10.62 10.62 2,391,778
Sep 9, 2026 11.24 11.48 11.02 11.47 11.47 2,804,776
Sep 8, 2026 10.56 11.44 10.40 11.37 11.37 2,737,328
Sep 4, 2026 10.51 10.77 10.51 10.64 10.64 1,306,871
Sep 3, 2026 10.98 11.08 10.41 10.64 10.64 2,128,709
Sep 2, 2026 10.58 11.01 10.47 10.90 10.90 2,068,790
Sep 1, 2026 10.42 10.66 10.32 10.57 10.57 1,578,326
Aug 31, 2026 10.30 10.54 10.13 10.49 10.49 1,520,523
Aug 28, 2026 10.97 10.97 10.33 10.36 10.36 1,563,599
Aug 27, 2026 10.63 10.96 10.57 10.82 10.82 1,427,221
Aug 26, 2026 10.79 10.90 10.69 10.77 10.77 1,368,113
Aug 25, 2026 10.98 11.17 10.87 10.88 10.88 1,842,282
Aug 24, 2026 11.03 11.05 10.61 10.78 10.78 2,358,156
Aug 21, 2026 11.10 11.49 10.94 11.08 11.08 3,051,326
Aug 20, 2026 11.53 11.62 11.07 11.09 11.09 3,294,718
Aug 19, 2026 11.29 11.74 11.19 11.73 11.73 3,024,296
Aug 18, 2026 10.50 11.21 10.30 11.01 11.01 4,582,559
Aug 17, 2026 10.80 11.20 10.50 10.65 10.65 11,151,659
Aug 14, 2026 10.04 10.07 9.68 10.04 10.04 1,634,137
Aug 13, 2026 10.27 10.43 10.07 10.10 10.10 2,584,839
Aug 12, 2026 9.77 10.43 9.74 10.23 10.23 4,006,398
Aug 11, 2026 9.29 9.77 9.16 9.76 9.76 2,180,219
Aug 10, 2026 9.20 9.30 9.04 9.24 9.24 1,529,755
Aug 7, 2026 8.80 9.20 8.80 9.19 9.19 2,016,649
Aug 6, 2026 8.45 8.79 8.40 8.74 8.74 1,594,002
Aug 5, 2026 8.68 8.79 8.45 8.50 8.50 1,599,949
Aug 4, 2026 8.40 8.71 8.36 8.59 8.59 2,231,589
Aug 3, 2026 8.29 8.49 8.18 8.40 8.40 3,327,377
Jul 31, 2026 8.44 8.56 8.15 8.17 8.17 2,151,848
Jul 30, 2026 8.37 8.53 8.27 8.47 8.47 2,686,427
Jul 29, 2026 8.51 8.61 8.29 8.36 8.36 1,785,320
Jul 28, 2026 8.61 8.66 8.30 8.45 8.45 2,373,435
Jul 27, 2026 8.64 8.86 8.47 8.64 8.64 1,539,831
Jul 24, 2026 8.66 8.71 8.43 8.51 8.51 1,166,170
Jul 23, 2026 8.50 8.68 8.32 8.62 8.62 1,811,982
Jul 22, 2026 8.84 8.89 8.58 8.59 8.59 1,865,677
Jul 21, 2026 8.70 9.13 8.67 8.93 8.93 1,584,522
Jul 20, 2026 8.95 9.15 8.63 8.71 8.71 2,496,875
Jul 17, 2026 9.07 9.21 8.81 8.97 8.97 1,880,853
Jul 16, 2026 9.90 9.94 8.87 9.16 9.16 2,719,495
Jul 15, 2026 9.68 10.04 9.48 9.96 9.96 1,322,841
Jul 14, 2026 9.87 9.98 9.63 9.70 9.70 1,427,317
Jul 13, 2026 10.14 10.19 9.76 9.88 9.88 1,437,618
Jul 10, 2026 10.51 10.53 10.06 10.20 10.20 1,875,628
Jul 9, 2026 10.16 10.94 10.15 10.54 10.54 2,429,217
Jul 8, 2026 10.22 10.43 9.91 10.27 10.27 3,201,097
Jul 7, 2026 9.80 10.51 9.64 10.33 10.33 2,873,909
Jul 6, 2026 9.54 9.83 9.43 9.66 9.66 2,407,688
Jul 2, 2026 9.56 9.74 9.41 9.64 9.64 1,834,116
Jul 1, 2026 9.91 10.05 9.44 9.47 9.47 2,181,238
Jun 30, 2026 9.98 10.19 9.79 9.82 9.82 2,450,039
Jun 29, 2026 9.80 9.98 9.65 9.90 9.90 2,062,985
Jun 26, 2026 9.78 10.09 9.61 9.84 9.84 8,123,877
Jun 25, 2026 9.79 10.24 9.71 9.76 9.76 2,238,745
Jun 24, 2026 10.17 10.39 9.73 9.85 9.85 2,764,741
Jun 23, 2026 9.83 10.62 9.80 10.12 10.12 2,756,825
Jun 22, 2026 9.51 10.14 9.41 9.97 9.97 5,162,261
Jun 18, 2026 10.00 10.39 9.37 9.43 9.43 6,114,283
Jun 17, 2026 9.19 9.74 8.62 9.64 9.64 7,403,976
Jun 16, 2026 8.99 9.11 8.67 8.94 8.94 2,329,712
Jun 15, 2026 8.94 9.26 8.76 8.99 8.99 2,467,340
Jun 12, 2026 8.65 8.96 8.62 8.94 8.94 2,696,811
Jun 11, 2026 8.74 8.88 8.57 8.70 8.70 2,765,380
Jun 10, 2026 8.44 8.84 8.26 8.74 8.74 2,666,690
Jun 9, 2026 8.28 8.51 8.07 8.47 8.47 2,426,942
Jun 8, 2026 8.31 8.40 8.12 8.16 8.16 1,502,428
Jun 5, 2026 8.82 8.88 8.16 8.25 8.25 1,348,701
Jun 4, 2026 8.50 8.95 8.43 8.80 8.80 1,824,482
Jun 3, 2026 8.17 8.37 8.11 8.35 8.35 2,044,890
Jun 2, 2026 8.81 8.90 8.14 8.31 8.31 3,053,570
Jun 1, 2026 8.90 9.04 8.60 8.93 8.93 2,064,852
May 29, 2026 9.16 9.27 8.96 9.01 9.01 2,405,075
May 28, 2026 8.50 9.16 8.48 9.15 9.15 3,389,058
May 27, 2026 8.24 8.65 8.22 8.54 8.54 2,569,322
May 26, 2026 8.21 8.33 8.14 8.29 8.29 2,041,844
May 22, 2026 8.23 8.36 8.12 8.23 8.23 2,032,363
May 21, 2026 8.00 8.30 7.86 8.22 8.22 2,313,277
May 20, 2026 7.99 8.36 7.99 8.03 8.03 4,664,766
May 19, 2026 8.31 8.31 7.93 7.99 7.99 2,959,650
May 18, 2026 9.17 9.24 8.36 8.38 8.38 2,984,672
May 15, 2026 9.29 9.36 9.04 9.16 9.16 2,373,738
May 14, 2026 9.33 9.60 9.07 9.50 9.50 2,843,003
May 13, 2026 8.99 9.34 8.94 9.24 9.24 2,777,243
May 12, 2026 9.30 9.30 8.96 9.16 9.16 3,703,259
May 11, 2026 9.67 9.73 9.18 9.28 9.28 3,520,980
May 8, 2026 9.62 9.72 9.30 9.65 9.65 2,097,014
May 7, 2026 9.69 9.85 9.54 9.68 9.68 2,104,529
May 6, 2026 9.80 9.97 9.55 9.71 9.71 3,791,930
May 5, 2026 9.34 9.85 9.08 9.71 9.71 4,217,483
May 4, 2026 9.37 9.84 9.35 9.77 9.77 2,811,546
May 1, 2026 9.37 9.52 9.16 9.43 9.43 2,294,139
Apr 30, 2026 9.23 9.39 9.12 9.37 9.37 2,761,248
Apr 29, 2026 9.21 9.34 9.06 9.21 9.21 2,522,629
Apr 28, 2026 9.59 9.75 9.21 9.32 9.32 1,958,954
Apr 27, 2026 9.49 9.96 9.44 9.52 9.52 2,548,532
Apr 24, 2026 9.60 9.63 9.36 9.49 9.49 2,643,427
Apr 23, 2026 9.64 9.74 9.38 9.59 9.59 2,519,925
Apr 22, 2026 9.54 9.80 9.46 9.66 9.66 2,810,782
Apr 21, 2026 9.44 9.50 9.03 9.32 9.32 3,517,608
Apr 20, 2026 9.73 9.75 9.40 9.52 9.52 3,482,761
Apr 17, 2026 8.99 9.86 8.99 9.82 9.82 5,327,264
Apr 16, 2026 8.91 8.93 8.69 8.86 8.86 2,018,404
Apr 15, 2026 8.76 9.00 8.65 8.91 8.91 2,555,103
Apr 14, 2026 8.91 9.06 8.63 8.76 8.76 2,608,220
Apr 13, 2026 8.73 9.07 8.70 8.86 8.86 2,846,201
Apr 10, 2026 9.31 9.43 8.50 8.79 8.79 3,124,948
Apr 9, 2026 8.37 9.31 8.33 9.30 9.30 5,116,592
Apr 8, 2026 8.76 8.80 8.28 8.42 8.42 4,028,946
Apr 7, 2026 7.99 8.47 7.95 8.34 8.34 4,371,984
Apr 6, 2026 8.51 8.54 8.06 8.07 8.07 3,080,140
Apr 2, 2026 8.09 8.73 8.09 8.49 8.49 4,374,012
Apr 1, 2026 8.68 8.75 8.23 8.33 8.33 3,350,222
Mar 31, 2026 7.53 8.56 7.53 8.47 8.47 5,429,790
Mar 30, 2026 7.56 7.65 7.38 7.40 7.40 3,140,900
Mar 27, 2026 8.02 8.07 7.53 7.55 7.55 2,823,214
Mar 26, 2026 8.13 8.43 7.95 8.07 8.07 3,679,944
Mar 25, 2026 8.23 8.45 8.18 8.33 8.33 3,471,766
Mar 24, 2026 8.05 8.19 7.79 8.10 8.10 3,646,313
Mar 23, 2026 8.34 8.40 8.03 8.10 8.10 3,844,128
Mar 20, 2026 8.26 8.41 8.04 8.18 8.18 4,158,496
Mar 19, 2026 8.49 8.54 8.25 8.27 8.27 3,029,572
Mar 18, 2026 8.67 8.70 8.43 8.49 8.49 2,561,655
Mar 17, 2026 8.61 8.89 8.61 8.68 8.68 2,610,909
Mar 16, 2026 8.84 9.04 8.46 8.63 8.63 3,999,650
Mar 13, 2026 8.92 9.03 8.50 8.76 8.76 3,725,201
Mar 12, 2026 9.40 9.45 8.75 8.87 8.87 5,509,835
Mar 11, 2026 9.85 9.88 9.43 9.50 9.50 3,984,066
Mar 10, 2026 10.02 10.18 9.73 9.87 9.87 4,639,782
Mar 9, 2026 10.18 10.25 9.77 9.94 9.94 5,819,423
Mar 6, 2026 10.25 10.53 10.06 10.27 10.27 5,611,234
Mar 5, 2026 11.03 11.10 10.23 10.33 10.33 7,391,177
Mar 4, 2026 10.95 11.23 10.72 11.04 11.04 5,971,595
Mar 3, 2026 10.73 11.50 10.66 10.76 10.76 7,818,104
Mar 2, 2026 8.72 11.00 8.64 10.98 10.98 17,225,621
Feb 27, 2026 9.50 9.58 8.72 8.94 8.94 5,515,977
Feb 26, 2026 9.41 9.63 8.91 9.59 9.59 8,047,021
Feb 25, 2026 9.29 9.76 9.17 9.50 9.50 7,848,260
Feb 24, 2026 8.45 8.99 8.43 8.96 8.96 6,355,067
Feb 23, 2026 7.76 8.45 7.70 8.41 8.41 6,361,359
Feb 20, 2026 6.99 8.00 6.99 7.78 7.78 13,003,872
Feb 19, 2026 6.90 7.34 6.85 7.03 7.03 9,715,433
Feb 18, 2026 7.06 7.24 6.78 6.88 6.88 11,558,121
Feb 17, 2026 6.41 7.13 6.23 6.99 6.99 51,578,447
Feb 13, 2026 9.19 9.34 8.83 8.88 8.88 3,831,938
Feb 12, 2026 9.20 9.25 8.92 9.06 9.06 2,606,596
Feb 11, 2026 9.02 9.17 8.63 9.16 9.16 3,835,567
Feb 10, 2026 9.56 9.69 9.00 9.03 9.03 4,485,025
Feb 9, 2026 9.43 9.63 9.07 9.43 9.43 3,887,010
Feb 6, 2026 9.08 9.29 8.95 9.16 9.16 4,095,040
Feb 5, 2026 8.85 10.08 8.84 8.91 8.91 8,948,515
Feb 4, 2026 8.50 8.70 8.37 8.55 8.55 6,855,543
Feb 3, 2026 9.16 9.24 8.36 8.51 8.51 6,868,424
Feb 2, 2026 9.15 9.36 9.02 9.15 9.15 4,870,289
Jan 30, 2026 9.85 10.02 9.02 9.14 9.14 7,115,109
Jan 29, 2026 10.22 10.64 9.91 9.95 9.95 4,306,459
Jan 28, 2026 10.83 10.83 10.25 10.28 10.28 2,948,211
Jan 27, 2026 10.81 11.13 10.66 10.85 10.85 2,933,209
Jan 26, 2026 10.20 10.95 10.15 10.89 10.89 3,047,876
Jan 23, 2026 11.15 11.15 10.18 10.27 10.27 4,878,479
Jan 22, 2026 11.45 11.55 11.10 11.12 11.12 3,716,086
Jan 21, 2026 11.41 11.50 11.03 11.42 11.42 4,157,934
Jan 20, 2026 11.10 11.88 11.05 11.45 11.45 3,540,976
Jan 16, 2026 11.18 11.94 10.77 11.27 11.27 6,653,459
Jan 15, 2026 12.53 13.03 10.90 11.28 11.28 27,765,797
Jan 14, 2026 10.50 11.13 9.96 11.07 11.07 7,102,980
Jan 13, 2026 10.55 10.60 10.08 10.43 10.43 4,002,579
Jan 12, 2026 11.82 11.96 10.49 10.69 10.69 5,495,376
Jan 9, 2026 11.41 11.57 11.14 11.26 11.26 2,662,027
Jan 8, 2026 11.60 11.81 11.23 11.38 11.38 2,710,398
Jan 7, 2026 11.41 11.65 11.20 11.50 11.50 2,457,846
Jan 6, 2026 11.54 11.55 10.92 11.25 11.25 3,493,849
Jan 5, 2026 11.87 11.98 11.31 11.55 11.55 3,049,836
Jan 2, 2026 12.08 12.19 11.60 11.82 11.82 2,499,117
Dec 31, 2025 12.15 12.24 12.06 12.14 12.14 2,023,664
Dec 30, 2025 12.24 12.45 12.15 12.20 12.20 2,190,169
Dec 29, 2025 12.61 12.66 12.26 12.30 12.30 2,089,664
Dec 26, 2025 12.66 12.75 12.48 12.56 12.56 1,151,580
Dec 24, 2025 12.65 12.81 12.59 12.71 12.71 922,364
Dec 23, 2025 12.86 13.06 12.65 12.74 12.74 2,015,001
Dec 22, 2025 12.70 12.99 12.39 12.96 12.96 3,905,838
Dec 19, 2025 12.99 13.21 12.27 12.56 12.56 7,004,123
Dec 18, 2025 13.87 13.91 12.95 12.98 12.98 4,259,157
Dec 17, 2025 14.35 14.64 13.59 13.72 13.72 3,224,616
Dec 16, 2025 14.12 14.53 14.12 14.39 14.39 3,146,562
Dec 15, 2025 14.63 14.85 14.13 14.17 14.17 3,350,313
Dec 12, 2025 14.83 15.38 14.35 14.56 14.56 2,833,954
Dec 11, 2025 15.40 15.57 14.55 14.67 14.67 3,609,857
Dec 10, 2025 16.06 16.14 15.31 15.41 15.41 3,794,135
Dec 9, 2025 16.12 16.31 15.57 15.95 15.95 5,014,078
Dec 8, 2025 14.58 16.44 14.58 16.11 16.11 16,926,977
Dec 5, 2025 12.49 12.69 12.35 12.58 12.58 2,685,137
Dec 4, 2025 11.48 13.00 11.41 12.43 12.43 5,820,479
Dec 3, 2025 11.25 11.57 11.17 11.46 11.46 2,252,152
Dec 2, 2025 11.70 11.80 11.14 11.25 11.25 2,409,567
Dec 1, 2025 12.06 12.06 11.61 11.71 11.71 2,024,739
Nov 28, 2025 12.15 12.27 11.99 12.15 12.15 1,229,346
Nov 26, 2025 12.19 12.19 11.86 12.14 12.14 2,367,175
Nov 25, 2025 12.10 12.27 11.77 12.13 12.13 2,284,461
Nov 24, 2025 12.33 12.50 11.72 12.10 12.10 4,266,856
Nov 21, 2025 11.67 12.36 11.63 12.24 12.24 3,277,561
Nov 20, 2025 12.23 12.55 11.68 11.72 11.72 2,658,393
Nov 19, 2025 11.75 12.37 11.66 12.10 12.10 2,842,621
Nov 18, 2025 11.84 11.97 11.54 11.76 11.76 2,959,253
Nov 17, 2025 11.40 12.03 11.08 11.89 11.89 6,094,434
Nov 14, 2025 11.17 11.56 11.12 11.30 11.30 1,339,962
Nov 13, 2025 11.38 11.60 11.18 11.19 11.19 1,544,769
Nov 12, 2025 11.26 11.71 11.18 11.49 11.49 1,830,580
Nov 11, 2025 10.78 11.24 10.78 11.22 11.22 2,284,310
Nov 10, 2025 10.97 11.09 10.68 10.83 10.83 1,568,242
Nov 7, 2025 10.63 10.88 10.30 10.85 10.85 1,604,769
Nov 6, 2025 10.73 10.93 10.60 10.63 10.63 1,779,079
Nov 5, 2025 11.03 11.10 10.57 10.81 10.81 1,925,072
Nov 4, 2025 11.20 11.36 10.40 10.90 10.90 3,318,858
Nov 3, 2025 11.64 11.70 11.33 11.41 11.41 2,194,292
Oct 31, 2025 11.81 12.07 11.65 11.66 11.66 2,642,235
Oct 30, 2025 11.67 12.10 11.49 11.82 11.82 2,850,584
Oct 29, 2025 11.50 11.70 11.31 11.48 11.48 1,670,698
Oct 28, 2025 11.52 11.70 11.47 11.53 11.53 1,596,337
Oct 27, 2025 11.50 11.71 11.25 11.55 11.55 1,227,818
Oct 24, 2025 11.64 11.78 11.46 11.49 11.49 1,658,343
Oct 23, 2025 11.31 11.51 11.26 11.44 11.44 1,247,646
Oct 22, 2025 11.75 11.84 11.28 11.34 11.34 1,902,659
Oct 21, 2025 12.18 12.19 11.60 11.77 11.77 1,853,662
Oct 20, 2025 12.02 12.22 11.75 12.18 12.18 2,374,884
Oct 17, 2025 11.94 12.16 11.48 11.84 11.84 3,399,099
Oct 16, 2025 12.00 12.33 11.84 12.20 12.20 3,447,621
Oct 15, 2025 11.30 11.94 11.25 11.94 11.94 3,476,147
Oct 14, 2025 11.83 11.86 11.10 11.23 11.23 3,003,846
Oct 13, 2025 11.78 12.25 11.63 11.85 11.85 2,872,145
Oct 10, 2025 11.93 12.02 11.34 11.78 11.78 3,445,043
Oct 9, 2025 11.89 12.26 11.77 11.94 11.94 4,070,164
Oct 8, 2025 11.59 12.54 11.56 11.91 11.91 4,267,101
Oct 7, 2025 10.96 11.53 10.93 11.52 11.52 3,729,958
Oct 6, 2025 11.48 11.73 10.85 10.97 10.97 3,660,540
Oct 3, 2025 11.40 11.77 11.11 11.41 11.41 8,120,341
Oct 2, 2025 11.03 11.22 10.63 11.06 11.06 4,190,161
Oct 1, 2025 12.05 12.37 10.94 11.04 11.04 8,886,395
Sep 30, 2025 12.78 12.88 11.52 11.69 11.69 7,581,172
Sep 29, 2025 12.65 12.71 12.30 12.53 12.53 1,611,241
Sep 26, 2025 12.24 12.97 12.13 12.53 12.53 1,977,972
Sep 25, 2025 12.52 12.64 12.01 12.24 12.24 2,404,729
Sep 24, 2025 12.26 12.78 12.26 12.56 12.56 2,708,605

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Ocular Therapeutix, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at OCUL, per a recent SEC DEF 14A filing. We estimate that the median employee at OCULAR THERAPEUTIX, INC is paid $247,396.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation